A national Pandemic Action Plan for flu

Views:
 
Category: Entertainment
     
 

Presentation Description

No description available.

Comments

By: Sidihaiba71 (126 month(s) ago)

thank U Harman I never thought that this presentation would be as useful as it is now giving the current (potential) outbreak of the swine flu. It was interesting mapping those data of the CDC and see how unprepared we are to face up the challenge .

 
 

By: Harman (126 month(s) ago)

good presentation

Presentation Transcript

PowerPoint Presentation:

Statistical Analysis Project By National College MBA Students Mohamed El Mokhtar and Louai Al Meqbeli

Project Charter :

Project Charter Project: The Establishment of a National Pandemic Action Plan for Influenza in the US. Organization: Center for Disease Control Target Completion date : December 2013 Team Members: Mohamed Sidi Haiba and Louai El Meqbeli Scope: The project will analyze the flaws of the existing process and propose alternative solutions to improve it.

Project Charter Cont’d:

Project Charter Cont’d Stakeholders : Physicians Patients Healthcare Providers Employers General Population Government

Project Charter – Objectives:

Project Charter – Objectives The Stated Goal: Increasing the supply and capacity of delivery of influenza vaccines The Strategies Identified : Developing an immunization policy to increase the demand for seasonal vaccines by an average rate of 10% a year. Increasing influenza vaccine production capacity accordingly. Promoting research and development for new influenza vaccines

Project Charter – Objectives Developing an immunization policy to increase demand for seasonal vaccines :

Project Charter – Objectives Developing an immunization policy to increase demand for seasonal vaccines Map the landscape Estimate the disease burden Develop regional plans of action and mobilize resources Encourage international coordination between between countries and regions of the world

Project Charter – Objectives Increasing influenza vaccine production capacity :

Project Charter – Objectives Increasing influenza vaccine production capacity The three most valuable options identified by WHO experts Include : 1.continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines.  

Project Charter – Objectives Promote research and development for new influenza vaccines :

Project Charter – Objectives Promote research and development for new influenza vaccines Develop more effective influenza vaccines using new technologies. The ideal product profile is a vaccine which is: safe and highly protective, preferably in all target groups, including infants, the elderly, pregnant women and immuno-suppressed individuals; is easily and economically produced on a large scale; is effective – preferably with a low dose of antigen; is delivered, ideally, as a single dose

Deployment Model Need Drivers CTQs Requirements :

Deployment Model Need Drivers CTQs Requirements Improving the uptake of the influenza vaccines in the USA Seasonal clinic Mobile Staff Client recall reminder Providers feedback Media campaign Enhance efficacy of exiting vaccines and promote research for new ones

PowerPoint Presentation:

Mapping The Process Through Analysis Of Existing Data

Mapping the existing process :

Mapping the existing process Influenza Vaccine Doses distributed, United States 1964-2004. % of persons aged ≥ 65 years who reported receiving Vaccination during the preceding 12 months, by race/ethnicity and survey year- national health interview survey, US 1989-2003. % of persons aged 18-64 years who reported receiving influenza vaccination during the preceding 12 months, by race/ethnicity and survey year-national health interview survey, US 1989-2003. Cumulative Monthly Influenza Vaccine Distribution for 1999, 2000, 2001, 2002, 2003-04, 2004-05. % of influenza Vaccination by month, selected priority US populations, BRFSS 2004-05

Determining the process variation:

Determining the process variation To achieve this objective, one needs first to examine the nature of the cause effects we are dealing with. Are they common or special? Giv en the data we have so far and the fact that our strategic approach is already known (improvement process), we know in advance that our variation type is stable and our cause effects are common.

Identifying the root causes:

Identifying the root causes Based on the analysis of existing data we have identified several root causes, but the most important are: Lack of education Difficulties to access Cost Vaccine shortages Gaps in R & D

Proposed Solutions :

Proposed Solutions Creating a robust and effective supply and delivery chain. Developing a stockpiles of vaccines. Resolving policy regulatory and coordination Broaden access to vaccination e.g. workplace, community, pharmacies, seasonal clinics. Raise the awareness of the public about the importance of vaccination (public information). Mandate employers to offer vaccine free of charge or at an affordable cost (on site if possible). Extend the requirement to public schools, nursing homes, kindergarten.

Cont’d Solutions :

Cont’d Solutions Enhance demand among vulnerable segments of the population “elderly people, i nfants, pregnant women, children etc…” Extend the critical period of coverage beyond December. Link Influenza vaccination with the delivery of other vaccination among adolescents.

Implementation Process:

Enhancement Strategies year 1 year 2 year 3 year 4 Client reminder/recall 10% 20% 30% 40% Multicomponent education 15% 30% 45% 60% Cost reduction 10% 20% 30% 40% Reducing difficulty to access 20% 40% 60% 80% Provider reminder /recall 10% 20% 30% 40% Implementation Process

Summary :

Summary Th e availability of data is a crucial step in statistical analysis. Although, we Were unable to obtain/collect all the data we needed, we had enough to kick start our mapping process and devise some of our proposed solutions. The three most valuable proposals identified by WHO experts include : continuing to promote seasonal influenza vaccine programmers, supporting the industry to sustain production capacity beyond seasonal demand and enabling some vaccine production facilities to change, at the onset of a pandemic, from producing inactivated vaccines to live attenuated vaccines. Finally, in order for the process to be efficiently implemented and to take root In the long run, the improvements achieved need to be maintained and Ultimately institutionalized. In this regard the institution of a process control level is of great importance.

Critique of the sources: :

Critique of the sources: Statistical Thinking (improving business performance) by R. Hoerl and R Snee Department of Health & Human Services HHS www.who.org Http://www.isixsigma.com/library/content/c001211a.asp . www.dtic.mil/ndia/2003 CMMI /Facemire. ppt

Thank you for your attention! Now do you have any Questions ?:

Thank you for your attention! Now do you have any Questions ?

authorStream Live Help